The winners and losers of Biden’s plans to expand coverage of weight-loss drugs US President Joe Biden wants to expand the ...

The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GLP-1 RA) ...

A diet and exercise can be tricky to stay on top of during the holidays, but Dr. Bellanger has a tip that takes just 10 ...

Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...

Music star Lizzo credits three healthy habits with helping her lose over 60 pounds without taking a GLP-1 drug like Ozempic.

A new study published in the journal Jama estimated that more than 137 million American adults are eligible for medications ...

Ozempic, a weight loss medication, can lead to both positive and negative mood changes. Learn how it affects personality and ...

On Nov. 26, CMS proposed reforms to the Medicare Advantage and Part D programs for contract year 2026, including changes to prior authorization and GLP-1 coverage. Here are 10 things ASC leaders and ...

Ah, Thanksgiving: a time to gather ’round with friends and family, reflect on what we’re grateful for, and, of course, eat.

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

Berberine, green tea extract and taurine are just some of the ingredients advertised as being able to ‘boost’ GLP-1 levels.

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.